| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/23/2011 | CN101981009A 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents |
| 02/23/2011 | CN101981008A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine II receptors |
| 02/23/2011 | CN101981007A Method for purification of pyridine, and method for production of chlorinated pyridine |
| 02/23/2011 | CN101981003A Amide compounds, compositions and uses thereof |
| 02/23/2011 | CN101979394A A method to inhibit ethylene responses in plants |
| 02/23/2011 | CN101979380A Method for synthesizing 3-methylpyridine |
| 02/22/2011 | US7893270 Reacting 2,4,4-tribromobicyclo[3.2.1]oct-2-ene in chlorobenzene with acetonitrile and sulfuric acid to produce 4-bromo-bicyclo[3.2.1]oct-3-en-2-one |
| 02/22/2011 | US7893268 Epithiolone analogues |
| 02/22/2011 | US7893099 Cyclopentane derivatives |
| 02/22/2011 | US7893094 Amphiphilic pyridinium compounds, method of making and use thereof |
| 02/22/2011 | US7893065 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 02/22/2011 | US7893042 Boc-glycyl-phenazopyridine; phenazopyridines covalently attached to various conjugates; useful for providing increased (oral) bioavailability with reduced side effects |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2350882C Transfection reagents |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/17/2011 | WO2011019681A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | WO2010065902A3 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 02/17/2011 | US20110040098 Organoactinide-, Organolanthanide-, and OrganoGroup-4-Mediated Hydrothiolation of Terminal Alkynes with Aliphatic, Aromatic and Benzylic Thiols |
| 02/17/2011 | US20110040094 1,3,4-trisubstituted benzenes |
| 02/17/2011 | US20110040092 process for making and using hof.rcn |
| 02/17/2011 | US20110039892 Iminopyridine derivative and use thereof |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039860 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 02/17/2011 | US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110039846 Iminopyridine derivatives and use thereof |
| 02/17/2011 | US20110039841 Novel compounds, their preparation and use |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/17/2011 | US20110039705 Granular agrochemical composition and method of producing the same |
| 02/17/2011 | US20110039467 Ionic liquid flame retardants |
| 02/17/2011 | US20110037024 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device |
| 02/17/2011 | DE112009000527T5 Hydroxyapatit mit auf dessen Oberfläche befindlichem Silber Hydroxyapatite with befindlichem on the surface of silver |
| 02/17/2011 | CA2771083A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | CA2770801A1 Pesticidal carboxamides |
| 02/16/2011 | EP2284153A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284152A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284151A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2035383B1 Process for making solid triphenylboron-pyridine |
| 02/16/2011 | EP1615866B1 Indene derivatives as pharmaceutical agents |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN101977905A 4-pyridinone compounds and their use for cancer |
| 02/16/2011 | CN101977899A Manufacturing method for a piperidine-3-ylcarbamate compound and optical resolution method therefor |
| 02/16/2011 | CN101973940A Continuously synthesizing method of sulfonic acid alkyl group ionic liquid |
| 02/16/2011 | CN101973937A Double extracting process of ricinine idiotoxin |
| 02/16/2011 | CN101973936A Preparation method of pyridone derivative |
| 02/16/2011 | CN101973935A Preparation method and application of N-substituted-3,5-dibenzal piperidine-4-one |
| 02/16/2011 | CN101973934A 1,5-disubstituted aryl-1,4-pentadiene-3-ketoxime ether compound and preparation method thereof and insecticidal activity application |
| 02/16/2011 | CN101973933A Bi(phenylpyridine) fluorene derivatives and binuclear liquid crystal polarized cyclometalated platinum complex |
| 02/16/2011 | CN101973932A Preparation method of bisacodyl |
| 02/16/2011 | CN101973931A Method for extracting pyridine from ammonium sulfate mother liquor |
| 02/16/2011 | CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger |
| 02/16/2011 | CN101972672A S-acylation L-cysteine and application of salt thereof as catalyst for asymmetrical organic synthesis reaction |
| 02/16/2011 | CN101759634B Composite method for cefpiramide midbody D-alpha-(4-Hydroxy-6-methylnicotinamido) hydroxyphenylacetic acid |
| 02/15/2011 | US7888509 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 02/15/2011 | US7888507 UV excitable fluorescent energy transfer dyes |
| 02/15/2011 | US7888376 Cholesteryl ester transfer protein (CETP) inhibitors; atherosclerosis and cardiovascular diseases; N-(1-(5-chloropyridin-2-yl)-1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenylethyl)-4-(trifluoromethyl)thiazol-2-amine; Alzheimer's, atherosclerosis, venous thrombosis, peripheral vascular disease |
| 02/15/2011 | US7888374 Inhibitors of c-jun N-terminal kinases |
| 02/15/2011 | US7888351 Organic compounds |
| 02/15/2011 | CA2626402C Potassium channel inhibitors |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2456411C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/15/2011 | CA2455453C Taxol enhancer compounds |
| 02/15/2011 | CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/10/2011 | WO2011016523A1 Process for production of bis-quaternary ammonium salt, and novel intermediate |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | US20110034698 Oxonium And Sulfonium Salts |
| 02/10/2011 | US20110034697 Process for preparing 2-hydroxy-4-substituted pyridines |
| 02/10/2011 | US20110034693 Preparation of methylpentamethylenediamine and methylpiperidine |
| 02/10/2011 | US20110034521 Compounds and methods for treating zinc matrix metalloprotease dependent diseases |
| 02/10/2011 | US20110034520 Inhibitors of P38 Map Kinase |
| 02/10/2011 | US20110034463 Type iii secretion inhibitors, analogs and uses thereof |
| 02/10/2011 | US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc. |
| 02/10/2011 | US20110031487 Compound for organic thin-film transistor and organic thin-film transistor using the compound |
| 02/10/2011 | CA2769563A1 Novel compounds as modulators of glucocorticoid receptors |
| 02/10/2011 | CA2768632A1 Process for the manufacture of pharmaceutically active compounds |
| 02/09/2011 | EP2281816A1 New crystalline pyrithione/zinc oxide complex and physiologic/antibiotic active composite containing the same |
| 02/09/2011 | EP2281810A1 Amide compounds, preparation methods and uses thereof |
| 02/09/2011 | EP2280948A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers. |
| 02/09/2011 | EP2280935A1 4-trimethylammonio-butyrates as cpt2 inhibitors |
| 02/09/2011 | EP1831184B1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 02/09/2011 | EP1689715B1 Tubulin inhibitors |
| 02/09/2011 | EP1644321B1 New benzamides as ppaty modulators |
| 02/09/2011 | EP1597252B1 Pyridine derivatives as fungicidal compounds |
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | CN1927831B N-sulfenate group diaromatic hydrazide derivative, preparation and application thereof |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970410A Pyridylaminoacetic acid compound |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101970406A Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/09/2011 | CN101967140A Deuterated crizotinib as well as derivant, preparation method and application thereof |
| 02/09/2011 | CN101967126A Chiral leucine ion liquid |
| 02/09/2011 | CN101967122A Process for extracting ricinine from castor-oil plants |
| 02/09/2011 | CN101967121A Process for extracting trigonelline |
| 02/09/2011 | CN101967120A Preparation method of 2-p-chlorobenzyl pyridine |
| 02/09/2011 | CN101967115A Synthesis and herbicidal activity of 3-substituted phenoxybenzamine-2-cyanoacrylate ethoxyethyl compound |